RFL logo

RAFAEL HOLDINGS INC-CLASS B

RFLNYSE
πŸ† #4075 by market capUS Equity
$663.86β–² $40.16 (+6.05%)
Simulated price
πŸ””
Track RFL
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 6.0%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$105M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+33.9%
High Growth
πŸ“ŠGross Margin
95.1%
High
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
106.7x
Expensive
Otter Score
60
Fair
No chart data available for RFL.

Trading Snapshot

Day Range
$655.44 – $671.42
52-Week Range
$1.12 – $3.96
Volume
$3.75B
Avg Volume
$3.24B
Shares Outstanding
52.0M
Next Earnings
Nov 1, 2026

Fundamentals Snapshot

Annual Revenue
$917,000
Last Q Revenue
$179,000
P/E Ratio
β€”
P/S Ratio
106.7x
EPS (TTM)
$-0.68
Dividend Yield
β€”
Dilution (1yr)
+109.7%

Why Investors Own RFL

  • βœ“High-growth profile β€” revenue up +21.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 44% gross margin and 18% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

RFL logo

RAFAEL HOLDINGS INC-CLASS B

RFL
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$917Kβ–² +44.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
54.0%β–Ό βˆ’28.8% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$26Mβ–Ό βˆ’74.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$19Mβ–² +137.2% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
51.2Mβ–² +109.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$45Mβ–² +$39M YoY
StockOtter Β· stockotter.space

About RAFAEL HOLDINGS INC-CLASS B

Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate. Its Real Estate segment manages and leases a commercial office complex, which features an integrated 800-space public parking facility. The Pharmaceutical division, conversely, focuses on developing and bringing to market therapies designed to capitalize on the metabolic distinctions between healthy cells and malignant ones. The firm's flagship drug candidate is CPI-613 (devimistat), currently undergoing evaluation in numerous clinical trials, including two pivotal Phase III registrational studies for the treatment of advanced pancreatic cancer and relapsed/refractory acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
60/100

Analyst Price Target

β“˜
Average Target
$712.81
β–² +7.4% Upside
High Target$797.38
Low Target$540.36
Based on 22 analysts

Latest News & Updates